FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097673617> ?p ?o ?g. }

• W3097673617 endingPage "684" @default.
• W3097673617 startingPage "675" @default.
• W3097673617 abstract "Quantification of oral mucositis that progresses during concomitant chemo-radiotherapy (CCRT) is essential for its management. It is important to determine the methods that are simple, reliable and beneficial in foreseeing mucositis at earlier stages of treatment.A prospective study was conducted on 100 oral cancer patients receiving CCRT following the inclusion criteria. Patients were evaluated for mucositis i.e. erythema and ulcers by using the World Health Organization (WHO) scale and the oral mucositis assessment scale (OMAS), whereas mature and immature cells were identified by exfoliative cytology. Clinical examination and procedure of oral cavity were performed before, on days 5, 17, and at the end of treatment.Oral mucositis was observed in all oral squamous cell carcinoma (OSCC) patients receiving CCRT on different days with noteworthy increase from day 5 of CCRT to the end of treatment. For OMAS grading related to ulceration and erythema, Grade 1 (7.2%; 34%) was most commonly seen on the 5th day of CCRT, Grade 2 (29%; 19%) and Grade 3 (19%) were most frequently seen at the 17th day and end of CCRT, accordingly. With respect to WHO scale grades 1 and 2 (18.3%; 21.5%) was most frequently observed at the 17th day of CCRT, whereas grades 3 and 4 (12.5%; 2%) was noted at the end of CCRT. There was statistically significant increase in the percentage of immature cells at the end of CCRT (99%). A significant association (P < 0.0000) was observed among the days of smear and maturation stages of epithelial cells as well as among WHO mucositis grading, OMAS and types of epithelial cells, respectively.According to the findings of the study, oral mucositis grade is directly proportional to the progressing days of CCRT. Oral mucositis is frequently related to adverse clinical outcomes, affecting the patient’s quality of life. It is essential to develop methods that can be employed for the assessment of CCRT associated oral mucositis." @default.
• W3097673617 created "2020-11-09" @default.
• W3097673617 creator A5000513836 @default.
• W3097673617 creator A5022714853 @default.
• W3097673617 creator A5034663827 @default.
• W3097673617 creator A5036773296 @default.
• W3097673617 creator A5045254474 @default.
• W3097673617 creator A5076687888 @default.
• W3097673617 date "2021-04-30" @default.
• W3097673617 modified "2023-09-27" @default.
• W3097673617 title "Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma" @default.
• W3097673617 cites W111945854 @default.
• W3097673617 cites W1491651242 @default.
• W3097673617 cites W1759456481 @default.
• W3097673617 cites W1978454448 @default.
• W3097673617 cites W1985010021 @default.
• W3097673617 cites W1986379544 @default.
• W3097673617 cites W1993281586 @default.
• W3097673617 cites W2000915744 @default.
• W3097673617 cites W2001925164 @default.
• W3097673617 cites W2016994623 @default.
• W3097673617 cites W2017846693 @default.
• W3097673617 cites W2023593837 @default.
• W3097673617 cites W2037912899 @default.
• W3097673617 cites W2051172784 @default.
• W3097673617 cites W2056548289 @default.
• W3097673617 cites W2062136885 @default.
• W3097673617 cites W2067222562 @default.
• W3097673617 cites W2090857574 @default.
• W3097673617 cites W2116645921 @default.
• W3097673617 cites W2117060699 @default.
• W3097673617 cites W2134914253 @default.
• W3097673617 cites W2154936675 @default.
• W3097673617 cites W2195048121 @default.
• W3097673617 cites W2252997914 @default.
• W3097673617 cites W2915882923 @default.
• W3097673617 cites W384745426 @default.
• W3097673617 cites W38731237 @default.
• W3097673617 doi "https://doi.org/10.3906/sag-2007-131" @default.
• W3097673617 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8203133" @default.
• W3097673617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33155791" @default.
• W3097673617 hasPublicationYear "2021" @default.
• W3097673617 type Work @default.
• W3097673617 sameAs 3097673617 @default.
• W3097673617 citedByCount "0" @default.
• W3097673617 crossrefType "journal-article" @default.
• W3097673617 hasAuthorship W3097673617A5000513836 @default.
• W3097673617 hasAuthorship W3097673617A5022714853 @default.
• W3097673617 hasAuthorship W3097673617A5034663827 @default.
• W3097673617 hasAuthorship W3097673617A5036773296 @default.
• W3097673617 hasAuthorship W3097673617A5045254474 @default.
• W3097673617 hasAuthorship W3097673617A5076687888 @default.
• W3097673617 hasBestOaLocation W30976736171 @default.
• W3097673617 hasConcept C126322002 @default.
• W3097673617 hasConcept C127413603 @default.
• W3097673617 hasConcept C142724271 @default.
• W3097673617 hasConcept C147176958 @default.
• W3097673617 hasConcept C16005928 @default.
• W3097673617 hasConcept C18823058 @default.
• W3097673617 hasConcept C199343813 @default.
• W3097673617 hasConcept C2777286243 @default.
• W3097673617 hasConcept C2778496288 @default.
• W3097673617 hasConcept C2779121184 @default.
• W3097673617 hasConcept C2779384505 @default.
• W3097673617 hasConcept C2986629439 @default.
• W3097673617 hasConcept C3018488765 @default.
• W3097673617 hasConcept C3019992690 @default.
• W3097673617 hasConcept C509974204 @default.
• W3097673617 hasConcept C71924100 @default.
• W3097673617 hasConcept C90924648 @default.
• W3097673617 hasConceptScore W3097673617C126322002 @default.
• W3097673617 hasConceptScore W3097673617C127413603 @default.
• W3097673617 hasConceptScore W3097673617C142724271 @default.
• W3097673617 hasConceptScore W3097673617C147176958 @default.
• W3097673617 hasConceptScore W3097673617C16005928 @default.
• W3097673617 hasConceptScore W3097673617C18823058 @default.
• W3097673617 hasConceptScore W3097673617C199343813 @default.
• W3097673617 hasConceptScore W3097673617C2777286243 @default.
• W3097673617 hasConceptScore W3097673617C2778496288 @default.
• W3097673617 hasConceptScore W3097673617C2779121184 @default.
• W3097673617 hasConceptScore W3097673617C2779384505 @default.
• W3097673617 hasConceptScore W3097673617C2986629439 @default.
• W3097673617 hasConceptScore W3097673617C3018488765 @default.
• W3097673617 hasConceptScore W3097673617C3019992690 @default.
• W3097673617 hasConceptScore W3097673617C509974204 @default.
• W3097673617 hasConceptScore W3097673617C71924100 @default.
• W3097673617 hasConceptScore W3097673617C90924648 @default.
• W3097673617 hasIssue "2" @default.
• W3097673617 hasLocation W30976736171 @default.
• W3097673617 hasLocation W30976736172 @default.
• W3097673617 hasLocation W30976736173 @default.
• W3097673617 hasOpenAccess W3097673617 @default.
• W3097673617 hasPrimaryLocation W30976736171 @default.
• W3097673617 hasRelatedWork W2013602932 @default.
• W3097673617 hasRelatedWork W2059051968 @default.
• W3097673617 hasRelatedWork W2064900812 @default.
• W3097673617 hasRelatedWork W2091657658 @default.
• W3097673617 hasRelatedWork W2336726368 @default.

• next